Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 29 of 138 for:    (domestic or partner) AND (violence OR abuse)

Impact of 'Samalochana' Program on Women Who Have Experienced Intimate Partner Violence (IPV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03813901
Recruitment Status : Completed
First Posted : January 23, 2019
Last Update Posted : March 5, 2019
Sponsor:
Collaborators:
Warwick Research Services
Arsha Vidya Study Centre, Tamilnadu, India
Information provided by (Responsible Party):
NMP Medical Research Institute

Brief Summary:

Violence has immediate effects on women's health, which in some cases, is fatal. Physical, mental and behavioural health consequences can also persist long after the violence has stopped. Violence against women and girls occurs in every country and culture and is rooted in social and cultural attitudes and norms that privilege men over women and boys over girls.

Research consistently finds that the more severe the abuse, the greater its impact on women's physical and mental health. In addition, the negative health consequences can persist long after abuse has stopped.Present work shares the impact of arsha vidya counselling for women who has been victim of violence.


Condition or disease Intervention/treatment Phase
Domestic Violence Intimate Partner Violence Other: Samalochana Counselling Other: Wait list control Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 102 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Advaita Vedanta and Counselling for Women Who Have Experienced Intimate Partner Violence: Impact on Women's Health
Actual Study Start Date : June 21, 2018
Actual Primary Completion Date : November 22, 2018
Actual Study Completion Date : December 21, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Women's Health

Arm Intervention/treatment
Experimental: Samalochana Counselling group
Arsha Vidya advaita vedanta based counselling were given to the women
Other: Samalochana Counselling
Counselling program was individual, based on advaita vedanta and traditional philosophical grounds to answer individual fears, concerns,conflicts and difficulties in order to cope and recover.

Wait-list control group
Wait list group were not given any supportive care during the period. After that, they were offered the similar program as Counselling group.
Other: Wait list control
Wait list had no intervention offered during the study period. Afterwards, they were offered the counselling for the same duration.




Primary Outcome Measures :
  1. Change in Quality of Life [ Time Frame: Change from baseline to 12-week ]
    Quality of Life was measured using SF-36 questionnaire


Secondary Outcome Measures :
  1. Change in Anxiety [ Time Frame: Change from Baseline to 12-weeks ]
    Anxiety was measured using Beck Anxiety Inventory



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Woman
  • Able to attend regular counselling
  • Planning to remain in area for next 6 months
  • have experience intimate partner violence (physical, emotional, psychological, and/or sexual), including coercive control from a current or former partner in the previous 12 months and no later than 3 years.

Exclusion Criteria:

  • Man
  • Under 19 years of age
  • Cannot attend at regular basis
  • Living outside of the selected study sites, or planning to relocate in next 4 months
  • Separated more than 3 years ago

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03813901


Locations
Layout table for location information
India
Divya
Jaipur, Rajasthan, India, 302019
Sponsors and Collaborators
NMP Medical Research Institute
Warwick Research Services
Arsha Vidya Study Centre, Tamilnadu, India
Investigators
Layout table for investigator information
Principal Investigator: Neha Sharma, PhD Warwick Research Services
Study Chair: Buddhatmananda Saraswati Arsha Vidya Study Centre, India
Study Director: Vandana Mishra Sarvatra International, South Africa

Layout table for additonal information
Responsible Party: NMP Medical Research Institute
ClinicalTrials.gov Identifier: NCT03813901     History of Changes
Other Study ID Numbers: NMP/Arsha 2091
First Posted: January 23, 2019    Key Record Dates
Last Update Posted: March 5, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No